Economic indicators suggest that China’s manufacturing sector is showing signs of recovery following a massive government stimulus to the economy. The package, which was the biggest since the pandemic, aimed to halt deflation and foster growth.

A month after it was originally announced, Reuters reported that the government is considering issuing debt worth $1.4 trillion in the next few years.  

The Caixin manufacturing purchasing managers index, by Caixin and S&P Global, rose 50.3 in October, compared to 49.3 in September.  The reading followed the publication of official statistics saying that factory activity, which had been contracting for five months, picked up in October. The results exceeded analysts’ expectations.  

“It’s very early days, but it’s certainly possible that the strong PMI readings reflect stimulus expectations,” according to Gavekal Dragonomics deputy China research director Chrisotpher Beddor.  

“Policymaker are going to need to deliver on the actual fiscal stimulus in order to sustain any gains,” he added.  

In September, China issued its 2024 negative list, outlining the industries where foreign investment is restricted or prohibited. The updated list removed two remaining restrictions on foreign investment in the manufacturing sector, according to state-owned media outlet Global Times.  

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The remaining restrictions concerned the publication, printing, application and production of traditional Chinese medicine. The new list takes effect today (November 1).